Corrigendum to 'Diagnostic adjudication of potential participants with chronic inflammatory demyelinating polyradiculoneuropathy in the ADHERE trial of subcutaneous efgartigimod PH20' [Journal of the Neurological Sciences, 486 (2026) 125918].
Donofrio PD, Gorson KC, Hofman E, Karam C, Kira J-I, Kostera-Pruszczyk A, Léger J-M, Nobile-Orazio E, Attarian S, Markov M, et al.
J Neurol Sci. 2026 May 13:125965. PMID: 42128722.Abstract
